An experimental drug that caused appalling side effects in a clinical trial nine years ago is back in tests for rheumatoid arthritis and is showing promise when given at a fraction of the original...
After you stare at a wall of running shoes for awhile, they all start blending together: the garish colors, the suspicious layers of gel, the absurd and vaguely mythic names.
Last year, scientists enlisted 40 recreational drug users to test one of the hottest questions in pharmaceutical research: Is it possible to develop a strong painkiller that doesn’t make people high?
Prescription drugs spending jumped 13 percent last year, the biggest annual increase since 2003, according to the nation's largest pharmacy benefits manager.
The brain's "pain sensor" has been found, researchers say. When you step on a thumbtack or hit your funny bone, this is the part of your brain that lights up.
Chronic inflammatory pain can be difficult to treat. When cold packs and other modalities aren’t helping, could a popular European cooling treatment be the answer some patients are looking for?
Gout, the most common type of inflammatory arthritis, affects an estimated 8.3 million Americans.